¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"maltese cross appearance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • spoke wheel appearance
    ¹ÙÄû»ì¸ð¾ç
  • stack coin appearance
    °ãÄ£µ¿Àü¸ð¾ç
  • step ladder appearance
    »ç´Ù¸®¸ð¾ç
  • stove pipe appearance
    ¿¬Åë¸ð¾ç
  • snake head appearance
    ¹ì¸Ó¸®¸ð¾ç, »çµÎÇü
  • snowman appearance
    ´«»ç¶÷¸ð¾ç
  • soap bubble appearance
    ºñ´©°Åǰ¸ð¾ç
  • blue cross
    û½ÊÀÚ
  • criss-cross inheritance
    ½ÊÀÚÀ¯Àü, À̼ºÀ¯Àü
  • cross
    ±³Â÷
  • cross absorption
    ±³Â÷Èí¼ö
  • cross birth
    ȾÀ§ºÐ¸¸
  • cross bridge
    ±³Â÷°áÇÕ, ¿¬°á´Ù¸®
  • cross bridge cycle
    ±³Â÷°áÇÕÁÖ±â
  • cross circulation
    ±³Â÷¼øÈ¯
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • soap bubble appearance
    ºñ´©°Åǰ¸ð¾ç
  • speckled appearance
    ¹ÝÁ¡¸ð¾ç
  • spider web appearance
    °Å¹ÌÁÙ¸ð¾ç
  • spoke wheel appearance
    ¸¶Â÷¹ÙÄû¸ð¾ç
  • stack coin appearance
    µ¿Àü°ãÄ£¸ð¾ç
  • step ladder appearance
    °è´Ü¸ð¾ç
  • stove pipe appearance
    ¿¬Åë¸ð¾ç
  • cross absorption
    ±³Â÷Èí¼ö
  • cross-modal association
    ±³Â÷½Ä¿¬ÇÕ
  • cross-reacting antibody
    ±³Â÷¹ÝÀÀÇ×ü
  • cross-reacting antigen
    ±³Â÷¹ÝÀÀÇ׿ø
  • blue cross
    û½ÊÀÚ
  • cross birth
    ³­»ê, ȾÀ§ºÐ¸¸
  • cross bridge
    ±³Â÷°áÇÕ, ¿¬°á´Ù¸®
  • cross
    ±³Â÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • immunity, cross
    ±³Â÷¸é¿ª
  • incision, cross hatching
    ±³Â÷Àý°³(¼ú)
  • plasma cross matching
    Ç÷Àå±³Â÷½ÃÇè(úìíìÎßó©ãËúÐ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • flame appearance
    ºÒ²É ¸ð¾ç
  • floatting teeth appearance
    À¯ÁÖ Ä¡¾Æ ¸ð¾ç
  • ground-glass appearance
    Á¥ºûÀ¯¸®¸ð¾ç
  • herring bone appearance
    û¾î»À ¸ð¾ç
  • iceberg appearance
    ºù»ê ¸ð¾ç
  • leafless tree appearance
    ÀÙ¾ø´Â ³ª¹« ¸ð¾ç
  • leather bottle appearance
    °¡Á×ÁÖ¸Ó´Ï ¸ð¾ç
  • onion peel appearance
    ¾çÆÄ ²®Áú ¸ð¾ç
  • orange peel appearance
    ¿À·»Áö²®Áú¸ð¾ç(¡­Ù¼åÆ)
  • pipestem appearance
    ÆÄÀÌÇÁ°ü ¸ð¾ç
  • punched-out appearance
    µµ·Á³½¸ð¾ç.
  • rugger jersey appearance
    ·°ºñ¿îµ¿º¹ ¸ð¾ç
  • rugger jersy appearance
  • salt and pepper appearance
    ¼Ò±Ý ÈÄÃß°¡·ç ¸ð¾ç
  • scotty dog appearance
    ½ºÄÚÆ®°³ ¸ð¾ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cross-reacting antibody
    ±³Â÷¹ÝÀÀ Ç×ü(Îßó©Úãëëù÷ô÷)
  • cross-reacting antigen
    ±³Â÷¹ÝÀÀ Ç׿ø(Îßó©Úãëëù÷ê«)
  • cross-reacting material
    ±³Â÷¹ÝÀÀ ¹°Áú(Îßó©ÚãëëÚªòõ)
  • cross-reaction
    ±³Â÷¹ÝÀÀ(Îßó©Úãëë)
  • cross-reactivation
    ±³Â÷ÀçȰ¼ºÈ­(Îßó©î¢üÀàõûù)
  • cross-resistance
    ±³Â÷ÀúÇ×(Îßó©î½ù÷)
  • cross-sensitization
    ±³Â÷°¨ÀÛ(Îßó©ÊïíÂ)
  • cross-term diffusion coefficient
    ¹æÇØ È®»ê°è¼ö(Ûªúªüªß¤Íªâ¦)
  • cross tolerance
    ±³Â÷³»¼º(Îßó©Ò±àõ)
  • genetic cross
    À¯Àü ±³Â÷(ë¶îîÎßó©)
  • helical cross
    ³ª¼± ½ÊÀÚ(Õ¢àÁä¨í®)
  • phage cross
    ÆäÀÌÁö ±³Â÷(Îßó©)
  • photoactivated cross-linking
    ±¤ºÎȰ ±³Â÷ ¿¬°á(ÎÃÝ¥üÀÎßó©Ö§Ì¿)
  • three-factor cross
    »ïÀÎÀÚ ±³Â÷ (ß²ì×í­Îßó©)
  • three-point cross
    ¼¼Á¡ ±³Â÷(Îßó©)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fishnet appearance
    ¾î¸Á¸ð¾ç
  • flame appearance
    ºÒ²É¸ð¾ç
  • floatting teeth appearance
    À¯ÁÖÄ¡¾Æ¸ð¾ç
  • ground glass appearance
    ºÒÅõ¸íÀ¯¸®¸ð¾ç, °£À¯¸®¸ð¾ç
  • H bomb appearance
    ¼ö¼ÒÆøÅº ¸ð¾ç
  • herring bone appearance
    û¾î»À¸ð¾ç
  • iceberg appearance
    ºù»ê ¸ð¾ç
  • leafless tree appearance
    ÀÙ¾ø´Â ³ª¹«¸ð¾ç
  • leather bottle appearance
    °¡Á×ÁָӴϸð¾ç
  • onion peel appearance
    ¾çÆÄ²®Áú¸ð¾ç
  • pipestem appearance
    ÆÄÀÌÇÁ°ü¸ð¾ç
  • rugger jersey appearance
    ·°ºñ¿îµ¿º¹¸ð¾ç
  • salt and pepper appearance
    ¼Ò±ÝÈÄÃß°¡·ç¸ð¾ç
  • sandwich appearance
    »÷µåÀ§Ä¡¸ð¾ç
  • saw tooth appearance
    Åé´Ï¸ð¾ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ARRC Associate of the Royal Red Cross
BC Bachelor of Surgery [Lat. Baccal-aureus Chirurgiae]; back care; bactericidal concentration; basal ce...
BCA balloon catheter angioplasty; bicinchoninic acid; blood color analyzer; Blue Cross Association; bran...
BC/BS Blue Cross/Blue Shield [plan]
BCBSA Blue Cross and Blue Shield Association
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CRD Cross Reacting Determinant
CSA Cross sectional areas
CCF Cross-correlation functions
CCH Cross-correlation histograms
CMM Cross-modality matching
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • snake head appearance
    ¹ì¸Ó¸® ¸ð¾ç, »çµÎÇü
  • soap bubble appearance
    ºñ´© °Åǰ ¸ð¾Ó
  • solitary appearance
    À¯ÀÏÇÑ ÇüÅÂ
  • speckled appearance
    ¹ÝÁ¡ ¸ð¾ç
  • stove pipe appearance
    ¿¬Åë ¸ð¾ç
  • swan-neck appearance
    ¸ñÀÌ ¾ÕÀ¸·Î ½ÉÇÏ°Ô ¸¸°îµÇ´Â ¾ç»ó
  • tobacco-pouch appearance
    ´ã¹è³¶ ¸ð¾ç
  • winter tree appearance
    °Ü¿ï³ª¹« ¸ð¾ç
  • wooden shoe appearance
    ³ª¸·½Å ¸ð¾ç
  • worm lik appearance
    Ãæ¾ç, ¹ú·¹ ¸ð¾ç
    ¹ú·¹¿Í ºñ½ÁÇÑ ÇØºÎÇÐÀû ±¸Á¶.
  • blue cross
    û½ÊÀÚ
  • cross
    ±³Â÷, ±³¹è, ±³Àâ
    ½ÊÀÚÀÇ Çüųª ±¸Á¶. ±³¹è¿¡ ÀÇÇØ ¸¸µé¾îÁø »ý¹°. ±³¹è ¹æ¹ý.
  • cross adaptation
    ±³Â÷ ¼øÀÀ
  • cross arch bar splint
    ¾Ç±³´ë ¿¬°á °íÁ¤ ÀåÄ¡
  • cross arch stabilization
    Ⱥ´ç Ä¡¿­±Ã ¾ÈÁ¤
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
cross-dressing Clothing oneself in the clothes of the opposite sex.
See: transvestism.
(05 Mar 2000)
cross-eye Alternative spelling for crossed eyes.
(05 Mar 2000)
cross flap A skin flap transferred from one part of the body to a corresponding part, as from one arm to the other.
(05 Mar 2000)
cross-hybridisation <molecular biology> The hydrogen bonding of asingle-stranded DNA sequence that is partially but not entirely complementary to a single-stranded substrate. Often, this involves hybridising a DNA probe for a specific DNA sequence to the homologous sequences of different species.
(09 Oct 1997)
cross hybridization Annealing of a DNA probe to an imperfectly matching DNA molecule.
(05 Mar 2000)
cross infection <microbiology> Infection transmitted between individuals infected with different pathogenic microorganisms. Any infection which a patient contracts in a health-care institution.
(12 Dec 1998)
cross-link A covalent linkage between two polymers or between two different regions of the same polymer.
(05 Mar 2000)
cross linking 1. <chemistry> The linking of the chains of a polymer to one another so that the polymer, as a network, becomes stronger and more resistant to being dissolved.
2. <molecular biology> The abnormal linking of two strands of DNA by covalent bonds (as opposed to the normal hydrogen bonds between base pairs), which can occur by exposure to X-rays. Such linking is a type of damage to the DNA molecule and must be repaired before the DNA can replicate and function properly again.
(09 Oct 1997)
cross-linking reagent <chemistry> Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other.
(12 Dec 1998)
cross-matching 1. A test for incompatibility between donor and recipient blood, carried out prior to transfusion to avoid potentially lethal haemolytic reactions between the donor's red blood cells and antibodies in the recipient's plasma, or the reverse; performed by mixing a sample of red blood cells of the donor with plasma of the recipient (major crossmatch) and the red blood cells of the recipient with the plasma of the donor (minor crossmatch). Incompatibility is indicated by clumping of red blood cells and contraindicates use of the donor's blood.
2. In allotransplantation of solid organs (e.g., kidney), a test for identification of antibody in the serum of potential allograft recipients which reacts directly with the lymphocytes or other cells of a potential allograft donor; presence of these antibodies usually, if not always, contraindicates the performance of the transplantation because virtually all such grafts will be subject to a hyperacute type of rejection.
(05 Mar 2000)
cross-pollination <botany> Fertilization of a plant from a plant with a different genetic makeup.
(09 Oct 1997)
cross-reacting agglutinin An immune agglutinin specific for a group antigen.
Synonym: cross-reacting agglutinin.
(05 Mar 2000)
cross-reacting antibody <immunology> Antibody specific for group antigens, i.e., those with identical functional groups, antibody for antigens that have functional groups of closely similar, but not identical, chemical structure.
(05 Mar 2000)
cross-reacting material <haematology> A substance sufficiently different from a reference substance (R) to have a perceptibly different function from R but sufficiently similar to R that it reacts with anti-R antibodies; e.g., mutant factor VIII may be defective or even inert in coagulation and yet be immunologically identified as factor VIII.
(05 Mar 2000)
cross reaction <haematology, immunology> Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Charing Cross
    丵 Å©·Î½º(·±´ø½ÃÀÇ Áß¾Ó,Strand°¡ ¼­ÂÊ ³¡ÀÇ ¹øÈ­ ±¸¿ª)
  • Geneva cross
    Àû½ÊÀÚ
  • George Cross
    Á¶Áö ÈÆÀå(George 4¼¼¶§ Á¦Á¤ 1943)
  • Greek cross
    ±×¸®½º ½ÊÀÚ°¡
  • Green Cross Code
    ±¹¹Î Çлý¿ë ±³Åë ¾ÈÀü ±ÔÄ¢
  • Holy Cross Day
    ¼º ½ÊÀÚ°¡ Âù¹ÌÀÇ ³¯(9¿ù 14ÀÏ)
  • International Committee of the Red Cross
    Àû½ÊÀÚ ±¹Á¦ À§¿øÈ¸(ICRC)
  • International Red Cross
    ±¹Á¦Àû½ÊÀÚ(»ç)(IRC)
  • Iron Cross
    (µ¶ÀÏÀÇ)ö½ÊÀÚ ÈÆÀå
  • Latin cross
    ¼¼·Î´ëÀÇ ¾Æ·¡ÂÊÀÌ ±ä º¸ÅëÀÇ ½ÊÀÚ°¡
  • Military Cross
    Àü°ø ½ÊÀÚ ÈÆÀå
  • Navy cross
    (¹Ì)ÇØ±º ¼öÈÆÀå;Ư°ø½ÊÀÚÈÆÀå
  • Northern Cross
    ºÏ½ÊÀÚ¼º(¹éÁ¶ÀÚ¸®)
  • Red Cross
    Àû½ÊÀÚ»ç;½ÊÀÚ±º(Ç¥Áö);(Èò ¹ÙÅÁ¿¡ ºÓÀº »öÀÇ)¼º Á¶Áö ½ÊÀÚÀå(À×±Û·£µåÀÇ ±¹Àå)
  • Roman cross
    ·Î¸¶ ½ÊÀÚ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á